T cell dysfunction and thymic involution are major immunologic abnormalities associated with aging. Fas (CD95) is a bifunctional molecule that is critical for apoptosis and stimulation during T cell development, but the role of Fas during aging has not been determined. Fas expression and function on T cells from old (22-26-mo-old) mice was compared with young (2-mo-old) mice and old CD2-Jhs-transgenic mice. Fas expression and ligand-induced apoptosis were decreased on T cells from old mice compared with young mice. This correlated with an age-related increase in CD44+Fas -T cells. There was a marked decrease in the proliferation of T cells from old mice after anti-CD3 stimulation compared with young mice. Anti-CD3-stimulated T cells from young mice exhibited increased production of interleukin (IL)-2 and decreased production of interferon-q/and IL-10 compared with old mice. There was an age-related decrease in the total thymocyte count from 127 _+ 10 cells in young mice compared with 26 + 8 x 106 in old mice. In 26-mo-old CD2-~s-transgenic mice, Fas and CD44 expression, Fas-induced apoptosis, T cell proliferation, and cytokine production were comparable to that of the young mice. These results suggest that T cell senescence with age is associated with defective apoptosis, and that the CD2-)hs transgene allows maintenance of Fas apoptosis function and T cell function in aged mice comparable to that of young mice.
,•e-related immune dysfunctions of T cells include thymic involution (1), decreased T cell response to mitogens or antigens (2) (3) (4) (5) (6) , altered cytokine expression (7) (8) (9) (10) , and altered phenotype (11) (12) (13) . The decrease in spleen or LN T cell responsiveness has been related to an increase in senescent memory T cells (11, D) , which exhibit defective phosphorylation after stimulation (14) (15) (16) (17) (18) . Thymic involution has been proposed to be due either to defects in thymocyte precursors derived from stem cells or a defect in expression of thymic factors or growth factors required for normal T cell development (19) (20) (21) (22) (23) . Recent evidence indicates that depletion of thymocyte stem cells cannot completely account for thymic involution with age (24) . Evidence to support an age-related deficiency of growth factors has been provided by the observation that replacement of growth factors or hormones can inhibit thymic involution or T cell dysfunction with aging (19) (20) (21) (22) (23) .
Fas/Apo-1 (CD95) is a cell surface-signaling molecule that mediates apoptosis (25, 26) . The apoptosis defect that results from defective Fas expression in Ipr mice results in survival of self-reactive T cells, loss of self-tolerance, autoimmunity, and lymphoproliferation (27) . There is a close association between apoptosis and proliferation mediated by Fas and other apoptosis molecules, including p53 and c-myc (28, 29) . Apoptosis that follows stimulation and proliferation has been proposed to be critical for the regulation of the T cell response to stimuli by removing cells with metabolic defects or autoimmune potential (30, 31) . We propose that this process of selective depletion of T cells is necessary throughout the life span of the animal to prevent accumulation of dysfunctional senescent T cells.
This article demonstrates that Fas expression and function are decreased in T cells of old mice. Age-related Fas dysfunction can be circumvented in CD2-Jhs-transgenic mice. The presence of the CD2-Jas transgene allows the maintenance of thymocyte numbers in aged mice comparable to that observed in young mice. The syngeneic mixed lymphocyte reaction (SMLtL) 1 and the response of peripheral T cells to stimulation by CD3 cross-linking is comparable to that of young animals. Cytokine expression after stimulation was also comparable to levels observed in young mice.
Materials and Methods
Mice. CD1 mice were obtained from Charles River Breeding Laboratories, Inc. (Wilmington, MA) and kept in specific pathogenfree conditions. Production of CD2fas Transgenic CD1 Mic~ CD1 mice were used for superovulation and production of the CD2-~s-transgenic mice as previously described (32) . The CD2-~s construct was made by ligation of a full-length murinefls cDNA into an EcoKI site in front of exon 1 of a human CD2 minigene consisting of 5.5 kb of the 5' flanking sequence, exon 1, the first intron, fused exons 2-5, and 2.1 kb of the 3' flanking sequence. The 3' sequence of this CD2 minigene has been shown to be sufficient to allow copydependent, integration-independent expression primarily in CD2 + T cells in transgenic mice (33, 34) . Transgenic mice were identified by tail DNA analysis and housed with littermate controls for 24 mo while being maintained on food and water ad libitum. The young 2-mo-old CD1 mice used in the experiments were derived from a breeding colony of CD1 mice.
Southern Blot Analysis. Tail DNA was prepared and digested with the indicated restriction enzymes. Approximately 10 #g of the digested DNA was separated on a 0.7% agarose gel, blotted to a nylon membrane, and hybridized with a 32p-labeled full-length Jhs cDNA probe extending from 49 to 1,033 bp of the murine sequence as previously described (32) .
Expression ofMurine Fas Ligand. The murine Fas ligand was cloned and sequenced using PCP, primers that were prepared according to the sequence of the known mouse Fas ligand (35, 36) . The full-length murine Fas ligand cDNA was cloned into the pcDNA1 expression vector (Invitrogen, San Diego, CA). 20 gg of purified plasmid DNA was precipitated with 500 gg/ml of DEAE-Dextran (Sigma Chemical Co., St. Louis, MO), added to 5 x 106 COS7 cells in a 10-cm cell culture dish containing 10 ml of serum-free RPMI 1640 and 10 mM chloroquine (Sigma Chemical Co., St. Louis, MO), and incubated at 37~ for 4 h. The transfected cells were then treated with 10% DMSO + RPMI 1640 for 2 min, and grown in 12% FCS + tLPMI 1640 for 72 h. The supernatant was collected and then stored at -20~ until use.
Preparation of Murine Fas-Human IgG1 Fusion Protein.
A murine Fas-human IgG1 (fas-hlg) fusion protein was prepared as previously described (37) . Briefly, the extracellular domain of the mouse Jhs cDNA was fused with the Fc portion of human IgG1 gene to form an open reading frame. The fusion gene was cloned into the pcDNA1 eukaryotic expression vector (Invitrogen) and transfected into COS7 cells as described above. The fusion protein was purified on an anti-human IgG agarose column (Sigma Chemical Co.) and concentrated to 1 mg/ml in PBS.
T Cell Enrichment. Single-cell suspensions of lymphocytes or spleen cells were enriched using a T cell enrichment column (K&D Systems, Inc., Minneapolis, MN) according to the directions of the manufacturer. Purified T cell populations were >98% T cells as determined by flow cytometry analysis of CD3 expression.
Flow Cytometry Analysis. Anti-CD3 (clone: 145.2Cll), anti-CD4 (clone: GK 1.5), anti-CD8 (clone: 53-47) and anti-CD44 (clone: 1M7), and anti-mouse Fas (clone: Jo2) were purchased from PharMingen (San Diego, CA). Single cell suspensions of lymphocytes, spleen cells, or thymocytes (10 6 per sample) were stained in FACS | buffer (PBS with 5% FCS and 0.1% sodium azide; Becton Dickinson & Co., Mountain View, CA) and optimal concentrations of antibodies. For two-and three-color analyses, cells were labeled with optimal concentrations of FITC-conjugated anti-CD4 and PE-conjugated anti-CD8 or biotin-conjugated anti-Fas or anti-CD44. Biotintylated conjugated antibodies were revealed by Tandem-avidin. Viable cells were determined by forward and side light scatter using standard methods and were <6% of the sample size. Viable cells (10, Assay of Cytokines. Cytokines were assayed using ELISA kits according to the manufacturer's instructions (Genzyme Corp., Cambridge, MA). The OD4os was measured on a microplate reader (Emax; Molecular Devices Corp., Menlo Park, CA). Duplicate samples were assayed in three separate experiments and the mean was determined. The statistical significance was determined using the Wilcoxon sign-rank nonparametric test.
In Situ Nick Translation Apoptosis Staining. Nuclear DNA fragmentation was carried out as previously described (38) . For cell suspensions, 10 s cells were cytospun onto poly-r-lysine (Sigma Chemical Co.) -precoated slides. The slides were fixed for 30 min in 10% formalin-PBS buffer and then washed with H20 for 2 min, six times. Fresh proteinase K (20 gg/ml; Boehringer Mannheim Corp., Indianapolis, IN) was added onto the slides and incubated at room temperature for 15 min. After washing with H20, terminal deoxynucleotide transferase (TdT) (1 U/ml; Boehringer Mannheim Corp.) and digitonigen-modified dUTP (0.15 /zl/ml; Boehringer Mannheim Corp.) was added in TdT buffer. A coverglass was applied and the slides incubated for 1 h at 37~ in a humidified chamber. After removing the coverglass, the slide was washed once with PBS, followed by incubation in 5% BSA/ FACS | buffer for 15 min at room temperature. The slides were incubated with an antidigoxigenin antibody conjugated to alkaline phosphatase (Boehringer Mannheim Corp.) at 1:50 dilution with FACS | buffer for 30 min at room temperature. After washing six times in PBS, the slides were incubated in alkaline phosphatase buffer with 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) (Sigma Chemical Co.) and incubated for 30 min at room temperature.
Statistical Analysis. Statistical analysis of proliferation and apoptosis after SMLK or anti-CD3 stimulation was carried out using the analysis of variance model at each time point.
Results

CD2-fas-transgenic Mice.
Tail DNA was prepared from mice at 4 wk of age, digested with EcoKI restriction enzyme, and hybridized with the full-length mouse Fas cDNA probe. One of the four founder CD1 CD2-fas-transgenic mice was identified as having a single 1.1-kb transgenic Fas cDNA integration band (Fig. 1, lane 3 ) and therefore mated with CD1 breeder mice. Transgenic and nontransgenic offspring of this mating were studied at ages 22-26 mo.
Fas Expression and Function on Lymphocytes. Cell surface
Fas expression was decreased on lymphocytes from 26-moold nontransgenic CD1 mice compared with 2-mo-old nontransgenic mice (Fig. 2) . Fas expression was increased to youthful levels in 26-mo-old CD1 CD2-fas-transgenic mice. Fas ligand-induced apoptosis was markedly decreased in LN
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T Cell Apoptosis and Aging cells from aged mice, and development of this apoptosis defect was prevented in CD2-J~s-transgenic aged mice (Fig. 3 ).
Syngeneic Mixed Lymphocyte Response. Spleen cells from
2-mo-old mice exhibited a weak SMLR characterized by a minimal proliferative response (Fig. 4 A) . This was not caused by an absence of IL-2 since the cells were cultured in the presence of 50 U/ml of Ib2. In contrast, there was a statistically significant increased proliferative response (p <0.001) after SMLR which peaked at 96 h using enriched spleen T cells of 26-mo-old mice. The SMLR response of spleen cells from 26-mo-old CD2-~s-transgenic mice was similar to that observed in 2-mo-old mice. On days 1 and 3 of the SMLR, there was minimum apoptosis (20-30%) in all three groups of mice (p <0.05). However, on days 5 and 7, apoptosis increased to 60-70% of spleen cells in both 2-and 26-mo-old CD2-fas-transgenic mice (Fig. 4 B) . In contrast, the percentage of cells undergoing apoptosis remained significantly lower in aged mice on days 5 and 7 of the SMLR (p <0.001). To determine if the cells undergoing SMLR were sensitive to Fas mediated apoptosis, SMLR was carried out in the presence of 1 #g/ml of purified anti-Fas antibody. Anti-Fas antibody did not prevent the SMLR proliferative responses by spleen cells from 26-mo-old nontransgenic mice and had no effect on the percentage of cells undergoing apoptosis (compare Fig. 4, A and B with Fig. 4, C and D) . Blocking of the Fas-Fas ligand interaction during SMLIL with a Fas fusion protein resulted in a statistically increased proliferative response and decreased apoptosis in young 2-mo-old mice and in 26-too-old CD2-fas-transgenic mice (Fig. 4 , E and F) (p <0.001). In contrast, the SMLR and apoptosis responses from 26-mo-old mice was not significantly affected by the presence of Fas fusion protein (p >0.05). These results indicate that the increased SMLR exhibited by spleen cells from 26-mo-old mice is associated with defective Fas signaling and apoptosis, which is present in 2-and in 26-too-old CD2-)~s-transgenic mice, and that the increased SMLR in aged mice is caused by a defect in apoptosis. This failure could not be corrected by stimulation with anti-Fas antibody, consistent with the finding that Fas expression is defective on T cells from aged mice.
Prevention of Age-related Decrease in Proliferation and Apoptosis in CD2fas-transgenic M/ca T cell proliferation after anti-
CD3 cross-linking peaked at 72 h in 2-too-old CD1 mice (Fig. 5 A) . In contrast, T cells from 26-mo-old mice exhibited a statistically significant decreased proliferative response (p <0.01) on days 2-4 after anti-CD3 cross-linking and a statistically significant increase (p <0.01) on days 5-7 after anti-CD3 cross-linking. The anti-CD3 proliferative responses in 26-too-old CD2-Jas-transgenic mice (and 2-mo-old CD2-fas-transgenic mice, data not shown) were significantly decreased ~ <0.01) but similar to those observed in 2-mo-old mice with peak proliferation on day 3 followed by a decrease in proliferation. Apoptosis after anti-CD3 stimulation was significantly increased (p <0.01) in 2-mo-old CD1 mice and in 26-too-old CD2-~s-transgenic mice compared with 26-mo-old nontransgenic mice (Fig. 5 B) .
Correction of Cytokine Response in CD2-fas-transgenic Aged
M/co Decreased Ib2 production after anti-CD3 cross-linking has been noted in old mice and humans (3-5). The 50% decrease in I1-2 production after anti-CD3 cross-linking in 22-mo-old mice was partially corrected in 22-mo-old CD2-.~s-transgenic mice (Fig. 6 A) . There was an increase in IL-4 production on days 2 and 4 after anti-CD3 cross-linking in aged mice compared with 2-mo-old mice, and this increase was partially prevented in 22-too-old CD2-fas-transgenic mice (Fig. 6 B) . There was also an increased production of IL-10, which peaked on day 6 in 22-and 2-mo-old mice in response to anti-CD3 cross-linking (Fig. 6 C) . This increased Ibl0 production was prevented in CD2-fas-transgenic mice. These results indicate that the aged mice exhibit a shift toward a Th2-type cytokine response (IL-4, Ibl0) rather than a Thl cytokine response (IL-2), and that this shift can be prevented in CD2-J~s-transgenic aged mice.
Correction of CD44 Expression on Thyraocytes and Spleen
Cells. Thymocyte subpopulations exhibiting defective Fas expression were primarily CD4 +CD8 + (double-positive) and CD4-CD8-(double-negative) thymocytes in 26-moold nontransgenic CD1 mice (Fig. 7 A) . Most of the thymocytes with low Fas expression exhibited increased expression of CD44. Thymocytes from 26-mo-old CD2-fas-transgenic mice were phenotypically similar to those from 2-mo-old mice. Less than 20% of enriched T cells from the spleen of 2-too-old nontransgenic mice express CD44, and "~90% were Fas +. In 26-too-old nontransgenic CD1 mice, 60% of 132 T Cell Apoptosis and Aging enriched spleen T cells were Fas-, and '~80% were CD44 +. In 26-mooold Fas-transgenic mice, expression of CD44, CD4, and Fas was similar to that observed in 2-mo-old mice.
Prevention of Thymic Involution in Aged CD2-fas-transgenic Mice.
There was a markedly decreased number of thymocytes in 22-mo-old CD1 mice compared with 2-mooold CD1 mice, which was prevented in the presence of the 22-too-old CD2-fas-transgenic mice (Fig. 8 A) . Consistent with the finding of increased thymocyte numbers in young and aged CD2 Fas-transgenic mice, thymocyte apoptosis was decreased in young and aged CD2-fas-transgenic mice on days 2-6 after CD3 cross-linking (Fig. 8 B) . In contrast, in 22-mo-old mice, there was increased apoptosis on days 2-6 after CD3 crosslinking, suggesting high utilization of programmed cell death mechanisms within the aged thymus. These results indicate that the CD2-fas transgene might provide an intrathymic signal for thymic development, thereby preventing apoptosis after CD3 cross-linking in vitro.
Discussion
The immunologic mechanism underlying defective Fas function with age is not known. One possibility is that there is an intrinsic age-related defect in transcriptional or the posttranscriptional factors that regulate Fas expression. This view is supported by the fact that Fas is a member of a family of receptors that contain cysteine repeat domains and this family of receptors includes TNF-R and CD40-L, which also exhibit decreased expression with age (39) (40) (41) . Another possibility is that the Fas signaling-function might be impaired with aging, which could further accentuate an expression defect. Fas signaling involves a phosphatase dependent pathway, which is decreased with aging (42) . Further investigation into the mechanisms of defective Fas signaling with aging could lead to novel intervention therapies to restore normal Fas signaling.
Our data indicate that Fas function is decreased more than Fas expression in old mice. One possibility is that high Fas expression is required for Fas-induced apoptosis. Previous results indicate that there are at least two pathways for apoptosis of thymocytes (28, 29, 43) . Apoptosis of thymocytes that have undergone DNA damage by x-irradiation require p53, whereas steroid-induced apoptosis does not. In the Fas-mutant llor mice, there is an increase in steroid-induced apoptosis of thymocytes, but a decrease in Fas-induced apoptosis caused by the Fas mutation (44) . The present results also indicate that there is more than one pathway for apoptosis of T cells in the thymus and LN. One is active in young mice, whereas a second Fas-independent pathway is active for deletion of T cells from aged mice after stimulation. The shift from Fas-dependent to Fas-independent apoptosis with aging may account for altered phenotype and function of T cells with aging.
CD44
Loss of Fas function with age is associated with a decrease of the Thl cytokine IL-2 and an increase of the Th2 cytokines II,-4 and IL-10. The overuse of the Th2 pathway with aging has also been previously reported by other investigators (45, 46) . We have shown recently that T cells that have been stimulated to undergo preferential development since Thl T cells express Fas and Fas ligand, whereas T cells stimulated to undergo development as Th2 T cells do not express Fas or Fas ligand (Zheng, R., J. Pan, J. Mountz, T. Zhou, and C. T. Weaver, manuscript submitted for publication). The shift of Thl to Th2 T cells with aging may be caused by defective Fas-Fas ligand signaling. The restoration of preferential development of Thl cells by theJas transgene in aged mice suggests that Fas interaction with its ligand has been corrected, and that Fas interaction may play a critical role in T cell development as well as T cell apoptosis with aging.
Immune system aging is associated with an increase in percentage of memory T cells characterized by expression of CD44 and CD45RO (11) (12) (13) (47) (48) (49) (50) . In 26-mo-old nontransgenic mice, approximately one third of thymocytes and 50-60% of purified spleen T cells, increased CD44 expression was associated with low expression of cell surface Fas. CD44 + memory T cells would therefore be insensitive to Fas-induced apoptosis. The percentage of CD44 + T cells was greatly reduced in CD2-J~s-transgenic aged mice. These results indicate that development of CD44 + memory T cells in aged mice is related to several aspects of cell development, including Fas expression. In both the spleen and thymus, there was also a small population of cells that express high Fas and also high CD44, indicating that other factors in addition to Fas expression influence CD44 expression.
Rescue of thymocytes from apoptosis by the provision of necessary signaling molecules or growth factors may be an important mechanism in the restoration of T cell function with aging. This is consistent with a number of reports that certain growth factors, including growth hormone from transplanted pituitary glands (23), can prevent age-related thymic atrophy. Fas has been proposed to serve as a costimulatory molecule during thymic development of T cells (51) , and our data show that decreased Fas expression and function with age leads to increased apoptosis of thymocytes. These results were unexpected because Fas was first identified as a molecule capable of inducing apoptosis in certain cell lines (25, 26) . However, it is likely that Fas signaling leads to different responses, depending on the cell type and stage of differentiation. In support of this, in Fas-defective lpr/Ipr mice, and Fas ligand-defective gld/gld mice, defective apoptosis of thymocytes has been difficult to detect (52) , and the primary defect in these mice is abnormal T cell differentiation and tolerance loss (53, 54) . Therefore, we propose that defective intrathymic Fas signaling with age leads to a developmental defect and increases thymocyte apoptosis by a Fas-independent pathway, and that defective Fas signaling plays a major role in development of thymic atrophy with aging.
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